Business Wire

Technology Innovation Institute Launches Pioneering Research Facility in Abu Dhabi for Key Industries in the Region

Share

Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced that its Directed Energy Research Center (DERC) has launched a state-of-the-art facility in Tawazun Industrial Park (TIP), a regional hub for strategic businesses in the safety and security sector offering world-class business infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220523005302/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

TII's DERC Launches New Labs (Photo: AETOSWire)

The facility comprises seven distinct workshops and five specialized laboratories. Each caters to a specific research domain from mechanical and electronics workshops, prototype test area, coil winding, armature filling, dielectric testing, and acoustic prototyping lab. The laboratories are Pulse Power Lab, Semi-Anechoic Chamber, Tempest Chamber, Acoustic Lab, and Laser Development Lab.

The facility hosts three mobile research laboratories that can be used in conjunction with the primary laboratories or be deployed in the field for outdoor testing, including two Electromagnetic Mobile Labs and a Mobile Laser Lab. Applications DERC focuses on include High-Power ElectroMagnetics(HPEM) and Electromagnetic Compatibility (EMC) testing. DERC also undertakes innovative research in the HPEM and Pulsed Power domain, along with prequalification tests for multiple industries in the region.

A first for the GCC, DERC’s facility conducts industry-leading Radio Frequencytesting to manufacture and characterize high power, solid-state devices. The facility also carries out highly sensitive Acoustic experiments that require a high degree of isolation from environmental sound and vibrations, supporting development and characterization of unusual acoustic transmitters and sensors.

The controlled environment in the labs identifies involuntary sound sources in complex electronic systems that might lead to side-channel leakage. DERC’s custom-developed optical vibration analysis tools can examine mechanical system behavior across a wide range of frequencies.

Additionally, the Center has also introduced groundbreaking Signal Electronics & Acoustics (SEA) prototypingto facilitate the local development of advanced solutions like small/high-density RF and acoustic devices. The facility can undertake soldering, complex mechanical assembly, testing while advancing prototyping in 3D printing.

DERC’s Mobile Laser lab is the first of its kind in the region to conduct laser experiments outdoors to explore propagation of a high-power laser and study the effect on targets at a distance in the arid Gulf environment. Emitting a multi-kW continuous laser, the lab is equipped with a telescope mounted on a pan-tilt, focusing a beam over a distance ranging from 200 m to 2,000 m. Connected to an electrical generator, the mobile lab is designed to be used autonomously outdoors under extreme temperatures of up to 50°C.

Speaking on the new facility, Dr. Ray O. Johnson, CEO of Technology Innovation Institute (TII) and Acting CEO, ASPIRE, said: “At TII, we are committed to attracting global talent to our research centers. Given this priority, we are proud to witness DERC’s phenomenal achievement with this facility. Such innovative hubs draw a growing number of researchers as well as customers keen to benefit from testing capabilities across varied sectors.”

Dr. Chaouki Kasmi, Chief Researcher, Directed Energy Research Center (DERC), said: “We are excited to finally witness the launch and cutting-edge capabilities of this new facility that will offer us a distinct advantage while giving the UAE much-needed autonomy when it comes to ensuring comprehensive testing and establishing a reliable supply chain.”

The Center’s achievement of bringing together multiple core capabilities under one roof provides opportunities to take HPEM testing to greater heights while enabling the testing of high-power lasers in compact environments.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Technology Innovation Institute
Sneha Sivanand
Comms@atrc.ae

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated18.10.2024 17:25:00 CEST | Press Release

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated The mandate of the BaFin’s special commissioner at flatexDEGIRO Bank AG (the “Company”) was terminated on September 30, 2024, following the successful elimination of the serious deficiencies identified in the 2022 special audit by the Company and a positive review by the special commissioner. flatexDEGIRO AG made this announcement on October 18, 2024, following a corresponding decision by the German Federal Financial Supervisory Authority (BaFin). Oliver Behrens, CEO of flatexDEGIRO, said: “We have realigned and sustainably strengthened our organizational structures and processes in constructive cooperation with BaFin and the special commissioner. We are thereby closing a regulatory chapter and again increase our focus on our customers and important growth projects. My special thanks go to all employees who, under the leadership of Steffen Jentsch, member of the bank's management board, have made it possible to reach th

Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication18.10.2024 16:00:00 CEST | Press Release

Biological Lattice Industries Corp. (BLI), a leading innovator in biofabrication and life sciences R&D, today announced the successful closing of a $1.8 million pre-seed investment round led by Greek venture capital firm Uni.Fund. In conjunction with this funding announcement , BLI is introducing its first all-in-one solution for biofabrication: BioLoom™, BLI's advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform designed to revolutionize biofabrication workflows. BLI, a US startup with R&D operations in Greece, aims to radically simplify biofabrication for the global R&D community by providing intelligent, automated tools that streamline the design, fabrication, and testing of biomaterials. Biomaterials are critical for a wide array of biological applications. The applications range from advanced 3D cell culture systems for human biology emulation to the next-generation of resorbable medical devices and drug delivery systems for tissue trauma repair. “

Gurobi Brings Decision Intelligence Summit to Amsterdam18.10.2024 15:00:00 CEST | Press Release

Gurobi Optimization, LLC, the leader in decision intelligence technology, is set to host the first annual EMEAI Decision Intelligence Summit (“Gurobi Summit”) at Amsterdam’s Capital C on November 5-6, 2024. Following the success of last month’s inaugural summit for the Americas in Las Vegas, the EMEAI Summit will bring together operations researchers, data scientists, and business leaders from across the region to explore the latest advancements in mathematical optimization and decision intelligence. The Gurobi Summit will feature special presentations from companies such as Accenture and ICRON. Several of the company’s partners—including Decide4AI, Decision Labs, LTPLabs, and ORMAE—will also be present to showcase their solutions and insights. The two-day event will be packed with informative presentations, exciting customer case studies, and interactive learning opportunities. Day 1 will feature keynotes, technical presentations, and panel discussions. Day 2 will be dedicated to hand

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting18.10.2024 14:00:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual meeting of the American Society of Anesthesiologists (ASA), taking place from October 18-22, 2024 in Philadelphia, Pennsylvania. Abstract A1187 — “Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy” will be presented as an oral presentation on Sunday, October 20, during the “Best Abstract” session, which runs from 8:00-11:00 a.m. ET, as well as the Education session which runs on Monday, October 21, from 1:30-2:30 p.m. ET. Abstract A2074 — “A Phase 3, Single-Arm Study of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor For Treatment of Acute Pain From Surgical and Non-surgical Conditions” will be present

SLB Announces Third-Quarter 2024 Results18.10.2024 12:50:00 CEST | Press Release

SLB (NYSE: SLB) today announced results for the third quarter of 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241016795721/en/ The exterior of the SLB headquarters in Houston, Texas. (Photo: Business Wire) Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2024Jun. 30, 2024Sept. 30, 2023SequentialYear-on-yearRevenue $9,159 $9,139 $8,310 - 10% Income before taxes - GAAP basis $1,507 $1,421 $1,395 6% 8% Income before taxes margin - GAAP basis 16.5% 15.5% 16.8% 91 bps -33 bps Net income attributable to SLB - GAAP basis $1,186 $1,112 $1,123 7% 6% Diluted EPS - GAAP basis $0.83 $0.77 $0.78 8% 6% Adjusted EBITDA* $2,343 $2,288 $2,081 2% 13% Adjusted EBITDA margin* 25.6% 25.0% 25.0% 55 bps 54 bps Pretax segment operating income* $1,902 $1,854 $1,683 3% 13% Pretax segment operating margin* 20.8% 20.3% 20.3% 48 bps 51 bps Net income attributable to SLB, excluding charges & cr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye